Miriã Cândida Oliveira
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Miriã Cândida Oliveira has a total of 122 co-authors. Here are the top co-authors by number of shared publications:
- Luis Vicente Franco Oliveira
Human Movement and Rehabilitation Graduate Program, Evangelical University of Goiás (UniEVANGELICA), Anápolis 75083-515, GO, Brazil
14 shared publications - Larissa Rodrigues Alves
Faculty of Medicine, Evangelical University of Goiás (UniEVANGELICA), Anápolis 75083-515, GO, Brazil
11 shared publications - Carlos Hassel Mendes Silva
Health Sciences Graduate Program (PPGCS), Faculty of Medical Sciences (FCMSCSP), Irmandade da Santa Casa de Misericórdia de São Paulo, São Paulo 01221-010, SP, Brazil
9 shared publications - Deise Aparecida de Almeida Pires Oliveira
Human Movement and Rehabilitation Graduate Program, Evangelical University of Goiás (UniEVANGELICA), Anápolis 75083-515, GO, Brazil
7 shared publications - João Pedro Ribeiro Afonso
Graduate Program in Human Movement and Rehabilitation (PPGMHR), Evangelical University of Goiás (UniEVANGELICA), Anápolis 75083-515, GO, Brazil
7 shared publications - Rodolfo Paula Vieira
Laboratory of Pulmonary and Exercise Immunology (LABPEI), Evangelical University of Goiás (UniEvangélica), Avenida Universitária Km 3,5, Anápolis 75083-515, GO, Brazil
7 shared publications
Latest Publications
- Open Access
- 16 November 2026
- Published by MDPI AG in Medical Sciences
- Vol. 14 (7) , 788
Conventional and Emerging Hematological Inflammatory Indices in Metabolic Syndrome: Narrative Review of Clinical Significance and Response to Bariatric Surgery
Background: Metabolic syndrome (MetS) is associated with chronic low-grade systemic inflammation. Complete blood count-derived inflammatory indices and biochemical ratios have emerged as accessible, low-cost markers of inflammation and potential indicators of cardiometabolic risk. Objective: This narrative review examined the clinical relevance of hematological inflammatory indices in MetS, focusing on the neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), monocyte-to-lymphocyte ratio (MLR), systemic immune-inflammation index (SII), systemic inflammation response index (SIRI), and pan-immune-inflammation value (PIV), as well as the uric acid-to-HDL cholesterol ratio (UHR) and changes following bariatric surgery (BS). Methods: A narrative literature review was conducted using PubMed/MEDLINE, Scopus, Web of Science, and Google Scholar, from database inception to September 2026. The review addressed the links between obesity, inflammation, and MetS, the associations of these markers with cardiometabolic abnormalities, and their potential changes following BS. Results: NLR showed the most consistent associations with MetS, insulin resistance, and cardiometabolic risk. Evidence for PLR was less consistent, while MLR remained comparatively underinvestigated. Higher SII values were associated with obesity, MetS, hypertension, and glycemic abnormalities, whereas SIRI was linked to cardiovascular risk and adverse cardiometabolic profiles. Elevated PIV was also associated with obesity, diabetes, MetS, and insulin resistance. UHR was associated with MetS, insulin resistance, and other cardiometabolic abnormalities, although its discriminatory performance and clinical applicability remain limited. Following BS, changes in hematological inflammatory indices have been reported alongside weight loss and improvements in metabolic and inflammatory profiles; however, evidence regarding postoperative changes in SII, SIRI, and particularly PIV remains limited. Conclusions: Hematological inflammatory indices and biochemical ratios may complement cardiometabolic assessment, but their associations with MetS vary across markers and populations. The lack of validated cutoffs and established incremental predictive value limits their current clinical application. Prospective studies are needed to establish their prognostic value and clinical utility.
- 16 November 2026
- Published by MDPI AG in Medical Sciences
- Vol. 14 (7) , 788
Open AccessConventional and Emerging Hematological Inflammatory Indices in Metabolic Syndrome: Narrative Review of Clinical Significance and Response to Bariatric Surgery
Background: Metabolic syndrome (MetS) is associated with chronic low-grade systemic inflammation. Complete blood count-derived inflammatory indices and biochemical ratios have emerged as accessible, low-cost markers of inflammation and potential indicators of cardiometabolic risk. Objective: This narrative review examined the clinical relevance of hematological inflammatory indices in MetS, focusing on the neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), monocyte-to-lymphocyte ratio (MLR), systemic immune-inflammation index (SII), systemic inflammation response index (SIRI), and pan-immune-inflammation value (PIV), as well as the uric acid-to-HDL cholesterol ratio (UHR) and changes following bariatric surgery (BS). Methods: A narrative literature review was conducted using PubMed/MEDLINE, Scopus, Web of Science, and Google Scholar, from database inception to September 2026. The review addressed the links between obesity, inflammation, and MetS, the associations of these markers with cardiometabolic abnormalities, and their potential changes following BS. Results: NLR showed the most consistent associations with MetS, insulin resistance, and cardiometabolic risk. Evidence for PLR was less consistent, while MLR remained comparatively underinvestigated. Higher SII values were associated with obesity, MetS, hypertension, and glycemic abnormalities, whereas SIRI was linked to cardiovascular risk and adverse cardiometabolic profiles. Elevated PIV was also associated with obesity, diabetes, MetS, and insulin resistance. UHR was associated with MetS, insulin resistance, and other cardiometabolic abnormalities, although its discriminatory performance and clinical applicability remain limited. Following BS, changes in hematological inflammatory indices have been reported alongside weight loss and improvements in metabolic and inflammatory profiles; however, evidence regarding postoperative changes in SII, SIRI, and particularly PIV remains limited. Conclusions: Hematological inflammatory indices and biochemical ratios may complement cardiometabolic assessment, but their associations with MetS vary across markers and populations. The lack of validated cutoffs and established incremental predictive value limits their current clinical application. Prospective studies are needed to establish their prognostic value and clinical utility.
- Open Access
- 7 October 2026
- Published by MDPI AG in Geriatrics
- Vol. 11 (5) , 143
Effects of Virtual Reality-Based Rehabilitation on Postural Balance in Older Adults: A Systematic Review
Background: Population aging has been accompanied by an increased incidence of falls, fractures, and functional disability, representing a major global public health challenge. In this context, virtual reality (VR)-based rehabilitation has emerged as an innovative therapeutic strategy providing multimodal sensory and motor stimulation, facilitating motor learning, and enhancing treatment adherence through gamified, interactive environments. Objective: To investigate the effectiveness of VR-based rehabilitation on postural balance training in older adults through a systematic review. Methods: This systematic review was conducted in accordance with PRISMA 2020 and prospectively registered in PROSPERO (CRD420261303119). Comprehensive literature searches were performed in PubMed, Scopus, Web of Science, LILACS, and SciELO to identify studies published between 2015 and 2026. Randomized and non-randomized clinical trials evaluating VR rehabilitation in adults aged 60 years and older, with postural balance as the primary outcome, were eligible. Methodological quality was assessed using the PEDro Scale, and certainty of evidence was evaluated using GRADE. Data were synthesized using a qualitative, descriptive approach. Results: Nine clinical trials of moderate-to-good methodological quality were included, evaluating non-immersive commercial exergames, semi-immersive, and immersive rehabilitation-dedicated systems. Overall, findings indicated that VR was associated with improvements in static and dynamic balance and functional mobility. Between-group analyses showed no statistically significant differences between VR and conventional rehabilitation in several trials, whereas superior effects for VR were reported in others, alongside greater participant engagement and adherence. Conclusions: VR-based rehabilitation is an effective intervention for improving static and dynamic balance and functional mobility in older adults. As a complementary strategy in geriatric physiotherapy, VR has the potential to reduce fall risk, preserve functional independence, and enhance rehabilitation outcomes. Nevertheless, additional high-quality randomized controlled trials with standardized protocols and long-term follow-up are warranted to strengthen the current evidence.
- 7 October 2026
- Published by MDPI AG in Geriatrics
- Vol. 11 (5) , 143
Open AccessEffects of Virtual Reality-Based Rehabilitation on Postural Balance in Older Adults: A Systematic Review
Background: Population aging has been accompanied by an increased incidence of falls, fractures, and functional disability, representing a major global public health challenge. In this context, virtual reality (VR)-based rehabilitation has emerged as an innovative therapeutic strategy providing multimodal sensory and motor stimulation, facilitating motor learning, and enhancing treatment adherence through gamified, interactive environments. Objective: To investigate the effectiveness of VR-based rehabilitation on postural balance training in older adults through a systematic review. Methods: This systematic review was conducted in accordance with PRISMA 2020 and prospectively registered in PROSPERO (CRD420261303119). Comprehensive literature searches were performed in PubMed, Scopus, Web of Science, LILACS, and SciELO to identify studies published between 2015 and 2026. Randomized and non-randomized clinical trials evaluating VR rehabilitation in adults aged 60 years and older, with postural balance as the primary outcome, were eligible. Methodological quality was assessed using the PEDro Scale, and certainty of evidence was evaluated using GRADE. Data were synthesized using a qualitative, descriptive approach. Results: Nine clinical trials of moderate-to-good methodological quality were included, evaluating non-immersive commercial exergames, semi-immersive, and immersive rehabilitation-dedicated systems. Overall, findings indicated that VR was associated with improvements in static and dynamic balance and functional mobility. Between-group analyses showed no statistically significant differences between VR and conventional rehabilitation in several trials, whereas superior effects for VR were reported in others, alongside greater participant engagement and adherence. Conclusions: VR-based rehabilitation is an effective intervention for improving static and dynamic balance and functional mobility in older adults. As a complementary strategy in geriatric physiotherapy, VR has the potential to reduce fall risk, preserve functional independence, and enhance rehabilitation outcomes. Nevertheless, additional high-quality randomized controlled trials with standardized protocols and long-term follow-up are warranted to strengthen the current evidence.
- Open Access
- 12 August 2026
- Published by MDPI AG in Medical Sciences
- Vol. 14 (4) , 473
Exercise-Based Interventions for the Management of Low Back Pain in Adolescents in School Settings: A Systematic Review
Background/Objectives: To synthesize the effects of school-based exercise interventions in adolescents with nonspecific low back pain. Methods: PubMed/MEDLINE, Scopus, Web of Science, CENTRAL, PEDro, ScienceDirect, and supplementary sources were searched through 21 May 2026. Randomized and quasi-randomized controlled trials involving adolescents aged 10–19 years and delivering exercise wholly or substantially within schools were eligible. Risk of bias was assessed using Cochrane RoB 1, and findings were synthesized narratively. Results: Of 1935 records, two randomized trials and one quasi-experimental controlled trial (194 allocated participants) were included. Fanucchi et al. reported between-group reductions in past-month pain of 2.2 cm on a 10-cm visual analogue scale (95% CI 1.0–3.5) at 3 months and 2.0 cm (95% CI 0.5–3.5) at 6 months; absolute reductions in 3-month low back pain prevalence were 24% (95% CI 4–41) and 40% (95% CI 18–57), respectively. Jones et al. reported a large effect size for pain severity after 8 weeks (ES = 1.47). Javadipour et al. reported favorable pain and motor-function outcomes, but incomplete and internally inconsistent reporting limited interpretation. No study assessed low-back-pain-related disability using a validated instrument. All studies had high risk of bias in at least one domain, most commonly blinding. Heterogeneity precluded meta-analysis. Conclusions: Limited evidence suggests that school-based exercise may reduce pain intensity and pain prevalence over six months and improve selected physical outcomes in adolescents aged 12–15 years. The small, heterogeneous evidence base and risk of bias preclude conclusions or recommendations regarding modality or dosage.
- 12 August 2026
- Published by MDPI AG in Medical Sciences
- Vol. 14 (4) , 473
Open AccessExercise-Based Interventions for the Management of Low Back Pain in Adolescents in School Settings: A Systematic Review
Background/Objectives: To synthesize the effects of school-based exercise interventions in adolescents with nonspecific low back pain. Methods: PubMed/MEDLINE, Scopus, Web of Science, CENTRAL, PEDro, ScienceDirect, and supplementary sources were searched through 21 May 2026. Randomized and quasi-randomized controlled trials involving adolescents aged 10–19 years and delivering exercise wholly or substantially within schools were eligible. Risk of bias was assessed using Cochrane RoB 1, and findings were synthesized narratively. Results: Of 1935 records, two randomized trials and one quasi-experimental controlled trial (194 allocated participants) were included. Fanucchi et al. reported between-group reductions in past-month pain of 2.2 cm on a 10-cm visual analogue scale (95% CI 1.0–3.5) at 3 months and 2.0 cm (95% CI 0.5–3.5) at 6 months; absolute reductions in 3-month low back pain prevalence were 24% (95% CI 4–41) and 40% (95% CI 18–57), respectively. Jones et al. reported a large effect size for pain severity after 8 weeks (ES = 1.47). Javadipour et al. reported favorable pain and motor-function outcomes, but incomplete and internally inconsistent reporting limited interpretation. No study assessed low-back-pain-related disability using a validated instrument. All studies had high risk of bias in at least one domain, most commonly blinding. Heterogeneity precluded meta-analysis. Conclusions: Limited evidence suggests that school-based exercise may reduce pain intensity and pain prevalence over six months and improve selected physical outcomes in adolescents aged 12–15 years. The small, heterogeneous evidence base and risk of bias preclude conclusions or recommendations regarding modality or dosage.
- Open Access
Heart Rate Recovery After Six-Minute Walk Test, Pulmonary Function, Dyspnea, and Functional Status After COVID-19
Introduction: Coronavirus disease 2019 (COVID-19) can cause persistent cardiovascular alterations, including autonomic dysfunction. Heart rate (HR) recovery (HRR) after exercise is a simple marker of autonomic modulation associated with functional capacity and clinical prognosis. Evaluating HRR during the six-minute walk test (6MWT) may help identify residual functional limitations in diverse patients. Objective: To compare pulmonary function, maximal inspiratory pressure (MIP), functional capacity, dyspnea, fatigue, and functional status in post-COVID-19 patients. Methods: This cross-sectional study included 75 adults (mean age: 47.6 ± 13.1 years; 54.7% male) who recovered from COVID-19 divided into 2 groups based on HRR 1 min after the 6MWT: delayed (≤12 beats/min); and non-delayed (>12 beats/min). Pulmonary function, MIP, exercise capacity (via 6MWT), dyspnea, muscle fatigue, and functional status were assessed. Results: Based on HRR 1 min after 6MWT, 27 (36%) participants were classified with abnormal HRR and 48 (64%) with normal HRR. There were statistical differences between the groups regarding demographic or clinical characteristics, pulmonary function, MIP, muscle fatigue, or functional status (p > 0.05). The delayed HRR group exhibited a smaller reduction in HR in first minute of recovery (ΔHR = 6 vs. 23 beats/min), higher baseline HR (p = 0.010), and greater dyspnea (p = 0.020). Furthermore, this group exhibited worse functional performance in the 6MWT, with shorter distance walked (437.33 vs. 494.27 m; p = 0.019) and a lower percentage of predicted distance (74.66 ± 12.98% vs. 82.94 ± 15.71%; p = 0.023) compared with the non-delayed HRR group. Conclusion: Delayed HRR post-COVID-19 was associated with poorer functional performance and greater dyspnea, regardless of pulmonary function. The blunted reduction in HRR after exertion suggests impaired cardiovascular autonomic modulation, possibly related to attenuated vagal reactivation, which may contribute to exercise intolerance observed in this population.
Open AccessHeart Rate Recovery After Six-Minute Walk Test, Pulmonary Function, Dyspnea, and Functional Status After COVID-19
Introduction: Coronavirus disease 2019 (COVID-19) can cause persistent cardiovascular alterations, including autonomic dysfunction. Heart rate (HR) recovery (HRR) after exercise is a simple marker of autonomic modulation associated with functional capacity and clinical prognosis. Evaluating HRR during the six-minute walk test (6MWT) may help identify residual functional limitations in diverse patients. Objective: To compare pulmonary function, maximal inspiratory pressure (MIP), functional capacity, dyspnea, fatigue, and functional status in post-COVID-19 patients. Methods: This cross-sectional study included 75 adults (mean age: 47.6 ± 13.1 years; 54.7% male) who recovered from COVID-19 divided into 2 groups based on HRR 1 min after the 6MWT: delayed (≤12 beats/min); and non-delayed (>12 beats/min). Pulmonary function, MIP, exercise capacity (via 6MWT), dyspnea, muscle fatigue, and functional status were assessed. Results: Based on HRR 1 min after 6MWT, 27 (36%) participants were classified with abnormal HRR and 48 (64%) with normal HRR. There were statistical differences between the groups regarding demographic or clinical characteristics, pulmonary function, MIP, muscle fatigue, or functional status (p > 0.05). The delayed HRR group exhibited a smaller reduction in HR in first minute of recovery (ΔHR = 6 vs. 23 beats/min), higher baseline HR (p = 0.010), and greater dyspnea (p = 0.020). Furthermore, this group exhibited worse functional performance in the 6MWT, with shorter distance walked (437.33 vs. 494.27 m; p = 0.019) and a lower percentage of predicted distance (74.66 ± 12.98% vs. 82.94 ± 15.71%; p = 0.023) compared with the non-delayed HRR group. Conclusion: Delayed HRR post-COVID-19 was associated with poorer functional performance and greater dyspnea, regardless of pulmonary function. The blunted reduction in HRR after exertion suggests impaired cardiovascular autonomic modulation, possibly related to attenuated vagal reactivation, which may contribute to exercise intolerance observed in this population.
- Open Access
Post-Traumatic Stress Disorder, Anxiety, and Depression in Post-COVID-19 Patients Undergoing Psychotherapy: A Nonrandomized Clinical Trial
Global estimates show a 17.9% prevalence of neuropsychiatric disorders in individuals recently hospitalized with COVID-19. Cognitive behavioral therapy (CBT) has been proposed as a nonpharmacological strategy to mitigate these effects. This study examined the potential effects of CBT on anxiety, depression, post-traumatic stress disorder (PTSD), and quality of life (QoL) in post-COVID-19 patients. This prospective, nonrandomized, single-center clinical trial involved 15 patients (mean age 53.4 years) who underwent weekly CBT sessions for six weeks. Between-group differences in anxiety and depression scores were non-significant (p > 0.05); however, significant intragroup improvements were observed in anxiety (p = 0.01), depression (p = 0.01), and PTSD (p = 0.01) after the intervention. Thus, CBT was associated with reduced anxiety, depression, and PTSD as well as improved quality of life in post-COVID-19 patients. Improvements in QoL were noted mainly in the domains of functional capacity, vitality, emotional aspects, and mental health. While these findings suggest that CBT may be beneficial for post-COVID-19 patients, the small sample size, absence of a control group, and short follow-up period limit the strength of our conclusions. Therefore, the results should be considered preliminary, and further randomized controlled trials with larger sample sizes are warranted.
Open AccessPost-Traumatic Stress Disorder, Anxiety, and Depression in Post-COVID-19 Patients Undergoing Psychotherapy: A Nonrandomized Clinical Trial
Global estimates show a 17.9% prevalence of neuropsychiatric disorders in individuals recently hospitalized with COVID-19. Cognitive behavioral therapy (CBT) has been proposed as a nonpharmacological strategy to mitigate these effects. This study examined the potential effects of CBT on anxiety, depression, post-traumatic stress disorder (PTSD), and quality of life (QoL) in post-COVID-19 patients. This prospective, nonrandomized, single-center clinical trial involved 15 patients (mean age 53.4 years) who underwent weekly CBT sessions for six weeks. Between-group differences in anxiety and depression scores were non-significant (p > 0.05); however, significant intragroup improvements were observed in anxiety (p = 0.01), depression (p = 0.01), and PTSD (p = 0.01) after the intervention. Thus, CBT was associated with reduced anxiety, depression, and PTSD as well as improved quality of life in post-COVID-19 patients. Improvements in QoL were noted mainly in the domains of functional capacity, vitality, emotional aspects, and mental health. While these findings suggest that CBT may be beneficial for post-COVID-19 patients, the small sample size, absence of a control group, and short follow-up period limit the strength of our conclusions. Therefore, the results should be considered preliminary, and further randomized controlled trials with larger sample sizes are warranted.
- Open Access
- 28 August 2025
- Published by MDPI AG in Preprints.org
Post-Traumatic Stress Disorder, Anxiety, and Depression in Post-COVID-19 Patients Undergoing Psychotherapy: A Nonrandomized Clinical Trial
In individuals recently hospitalized with COVID-19, global estimates show a 17.9% prevalence of neuropsychiatric disorders. Cognitive behavioral therapy (CBT) is a viable alternative to reduce the harmful effects of the COVID-19 pandemic on mental health. This study aimed to verify the effect of CBT on anxiety, depression, post-traumatic stress disorder (PTSD), and quality of life (QOL) in hospitalized post-COVID-19 patients. This was a prospective clinical trial involving individuals with neuropsychiatric symptoms. Clinical data were collected, and the Hospital Anxiety and Depression Scale, Event Impact Scale (IES-6), and Short-Form Health Survey were administered. Fifteen patients (mean age 53.4 years), seven hospitalized in the COVID-19 ward and eight in the intensive care unit, underwent CBT sessions once a week for 50 min for a period of six weeks. The groups showed similar anxiety and depression scores (p>0.05) before and after CBT. However, there were significant intragroup differences in anxiety (p=0.01), depression (p=0.01), and PTSD (p=0.01) scores before and after CBT. Thus, CBT effectively reduced anxiety, depression, and PTSD, and improved QOL in post-COVID-19 patients.
- 28 August 2025
- Published by MDPI AG in Preprints.org
Open AccessPost-Traumatic Stress Disorder, Anxiety, and Depression in Post-COVID-19 Patients Undergoing Psychotherapy: A Nonrandomized Clinical Trial
In individuals recently hospitalized with COVID-19, global estimates show a 17.9% prevalence of neuropsychiatric disorders. Cognitive behavioral therapy (CBT) is a viable alternative to reduce the harmful effects of the COVID-19 pandemic on mental health. This study aimed to verify the effect of CBT on anxiety, depression, post-traumatic stress disorder (PTSD), and quality of life (QOL) in hospitalized post-COVID-19 patients. This was a prospective clinical trial involving individuals with neuropsychiatric symptoms. Clinical data were collected, and the Hospital Anxiety and Depression Scale, Event Impact Scale (IES-6), and Short-Form Health Survey were administered. Fifteen patients (mean age 53.4 years), seven hospitalized in the COVID-19 ward and eight in the intensive care unit, underwent CBT sessions once a week for 50 min for a period of six weeks. The groups showed similar anxiety and depression scores (p>0.05) before and after CBT. However, there were significant intragroup differences in anxiety (p=0.01), depression (p=0.01), and PTSD (p=0.01) scores before and after CBT. Thus, CBT effectively reduced anxiety, depression, and PTSD, and improved QOL in post-COVID-19 patients.
- Open Access
- 25 February 2025
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 22 (3) , 338
Health-Related Quality of Life and Functional Status of Post-COVID-19 Patients
Background: COVID-19 mainly affects the respiratory system, although its manifestations are multisystemic. We are increasingly recognizing complications that present after the acute phase, which are associated with impaired functional status and health-related quality of life (HRQoL). The objective was to assess the functional status and HRQoL of patients with post-COVID-19. Methods: This was a cross-sectional study involving individuals affected by COVID-19 who had persistent symptoms for one month after the acute phase of the disease. Functional status was measured with the six-minute walk test (6MWT), the Fatigue Severity Scale (FSS), the Medical Research Council (MRC) Dyspnea Scale, and the Post-COVID-19 Functional Status Scale (PCFS). HRQoL was confirmed with the Short-Form Health Survey 36 (SF-36). Results: We included 123 patients; 73 (59.35%) were male, with a mean age of 49.17 ± 13.48 years and a body mass index of 31.02 ± 6.56 stratified into three groups: the not-recovered group (NRG = 23), the ward-recovered group (WHG = 60), and the intensive-care-unit group (ICUG = 40). The main symptoms were muscle weakness (74.17%) and dyspnea (68.33%). The predicted distances for the 6MWT were missed by 12.83% by the GNR group, 20.21% by the GNR group, and 28.82% by the UGCI group. The MRC dyspnea scale had a mean value of less than 3, and the FSS scale had a mean value of over 4, indicating considerable fatigue. In the PCFS scale, a significant difference was observed (p < 0.0005), while in the SF-36, all HRQoL domains were compromised. Conclusion: Post-COVID-19 patients involved in this study showed a significant decline in functional status and an impairment of HRQoL.
- 25 February 2025
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 22 (3) , 338
Open AccessHealth-Related Quality of Life and Functional Status of Post-COVID-19 Patients
Background: COVID-19 mainly affects the respiratory system, although its manifestations are multisystemic. We are increasingly recognizing complications that present after the acute phase, which are associated with impaired functional status and health-related quality of life (HRQoL). The objective was to assess the functional status and HRQoL of patients with post-COVID-19. Methods: This was a cross-sectional study involving individuals affected by COVID-19 who had persistent symptoms for one month after the acute phase of the disease. Functional status was measured with the six-minute walk test (6MWT), the Fatigue Severity Scale (FSS), the Medical Research Council (MRC) Dyspnea Scale, and the Post-COVID-19 Functional Status Scale (PCFS). HRQoL was confirmed with the Short-Form Health Survey 36 (SF-36). Results: We included 123 patients; 73 (59.35%) were male, with a mean age of 49.17 ± 13.48 years and a body mass index of 31.02 ± 6.56 stratified into three groups: the not-recovered group (NRG = 23), the ward-recovered group (WHG = 60), and the intensive-care-unit group (ICUG = 40). The main symptoms were muscle weakness (74.17%) and dyspnea (68.33%). The predicted distances for the 6MWT were missed by 12.83% by the GNR group, 20.21% by the GNR group, and 28.82% by the UGCI group. The MRC dyspnea scale had a mean value of less than 3, and the FSS scale had a mean value of over 4, indicating considerable fatigue. In the PCFS scale, a significant difference was observed (p < 0.0005), while in the SF-36, all HRQoL domains were compromised. Conclusion: Post-COVID-19 patients involved in this study showed a significant decline in functional status and an impairment of HRQoL.
- Open Access
- 1 November 2024
- Published by Brazilian Journals in Cuadernos de Educación y Desarrollo
- Vol. 16 (11) , e6326
Domineidon is a big black gorilla. A psychiatric case report
Introduction: Schizophrenia affects about 1% of the population, starting before the age of 25 and persisting throughout life. The disease is characterized by the presence of positive symptoms such as delusions, hallucinations, thought disorganization, negative symptoms such as affective flattening, withdrawal, isolation, as well as cognitive symptoms, such as changes in attention and memory. Objective: To report a case of severe schizophrenia that presented a high degree of functional impairment and life cycle disruption. Methods: These informations was obtained through the collection of clinical data from the patient's medical record, information from family members and, the clinical evaluation. Results: The patient's mother reported the onset of symptoms at the age of 16, when her son would get very irritable for any reason. After killing his stepfather, the patient was caught in the act and taken to the Juvenile Detention Center. The patient tried to hang himself with his own hands several times, and was then admitted to a psychiatric clinic. He was treated with clozapine, starting with 25 mg and reaching a dose of 700 mg per day, without side effects of neutropenia, seizures, and sialorrhea. During his evolution, while still hospitalized, he showed good progress, with a reduction in delusions and hallucinations, demonstrating insight into his illness and self-criticism, returning to functionality. After being discharged from the hospital, he returned to social life with the family. Discussion: Schizophrenia can evolve severely, leading to the breakdown of the patient's life cycle, serious dysfunctions, and irreversible damage in biological, psychological, and social aspects. Poor adherence to treatment, the side effects of medications, refractoriness to drugs and therapies, as well as the use of illicit drugs, can be elements that, individually or in combination, worsen the prognosis of the disease. The use of clozapine is an important resource that can be used in cases refractory to other medications, bringing results. Conclusion: Even in the face of the patient's severe condition, there was a good response to treatment with clozapine.
- 1 November 2024
- Published by Brazilian Journals in Cuadernos de Educación y Desarrollo
- Vol. 16 (11) , e6326
Open AccessDomineidon is a big black gorilla. A psychiatric case report
Introduction: Schizophrenia affects about 1% of the population, starting before the age of 25 and persisting throughout life. The disease is characterized by the presence of positive symptoms such as delusions, hallucinations, thought disorganization, negative symptoms such as affective flattening, withdrawal, isolation, as well as cognitive symptoms, such as changes in attention and memory. Objective: To report a case of severe schizophrenia that presented a high degree of functional impairment and life cycle disruption. Methods: These informations was obtained through the collection of clinical data from the patient's medical record, information from family members and, the clinical evaluation. Results: The patient's mother reported the onset of symptoms at the age of 16, when her son would get very irritable for any reason. After killing his stepfather, the patient was caught in the act and taken to the Juvenile Detention Center. The patient tried to hang himself with his own hands several times, and was then admitted to a psychiatric clinic. He was treated with clozapine, starting with 25 mg and reaching a dose of 700 mg per day, without side effects of neutropenia, seizures, and sialorrhea. During his evolution, while still hospitalized, he showed good progress, with a reduction in delusions and hallucinations, demonstrating insight into his illness and self-criticism, returning to functionality. After being discharged from the hospital, he returned to social life with the family. Discussion: Schizophrenia can evolve severely, leading to the breakdown of the patient's life cycle, serious dysfunctions, and irreversible damage in biological, psychological, and social aspects. Poor adherence to treatment, the side effects of medications, refractoriness to drugs and therapies, as well as the use of illicit drugs, can be elements that, individually or in combination, worsen the prognosis of the disease. The use of clozapine is an important resource that can be used in cases refractory to other medications, bringing results. Conclusion: Even in the face of the patient's severe condition, there was a good response to treatment with clozapine.
- Open Access
- 31 October 2024
- Published by MDPI AG in Preprints.org
Health-Related Quality of Life and Functional Status of Post-COVID-19 Patients
Background: COVID-19 mainly affects the respiratory system, although its manifestations are multisystemic. Increasingly, complications presented after the acute phase are still being rec-ognized and are associated with impaired functional status and health-related quality of life (HRQoL). The objective was assess the functional status and HRQoL of patients with post-COVID-19. Methods: This was a cross-sectional study involving individuals affected by COVID-19 who had persistent symptoms for one month after the acute phase of the disease. HRQoL was verified through the Short Form Health Survey 36 (SF-36) and, functional status was assessed using the six-minute walk test (6MWT), the Fatigue Severity Scale (FSS), the Med-ical Research Council (MRC) Dyspnea Scale and, the Post-COVID-19 Functional Status Scale (PCFS). Results: Were included 123 patients, 73 (59.35%) were male, with a mean age of 49.17±13.48 years and a body mass index of 31.02±6.56 stratified into three groups, not recov-ered group (NRG=23), ward recovered group (WHG=60), and intensive care unit group (ICUG=40). The main symptoms were muscle weakness (74.17%) and dyspnea (68.33%). In rela-tion to the distance covered in the 6MWT, the GNR group walked 12.83% below the predicted values, GNR 20.21% and the UGCI 28.82%, respectively. The MRC dyspnea scale had a mean value of less than 3 and the FSS scale had a mean value over 4, indicating considerable fatigue. In the PCFS scale, a significant difference was observed (p>0.0005); while in the SF-36, all HRQoL domains were compromised. Conclusion: Post-COVID-19 patients involved in this study showed a significant decline in functional status and an impairment of HRQoL.
- 31 October 2024
- Published by MDPI AG in Preprints.org
Open AccessHealth-Related Quality of Life and Functional Status of Post-COVID-19 Patients
Background: COVID-19 mainly affects the respiratory system, although its manifestations are multisystemic. Increasingly, complications presented after the acute phase are still being rec-ognized and are associated with impaired functional status and health-related quality of life (HRQoL). The objective was assess the functional status and HRQoL of patients with post-COVID-19. Methods: This was a cross-sectional study involving individuals affected by COVID-19 who had persistent symptoms for one month after the acute phase of the disease. HRQoL was verified through the Short Form Health Survey 36 (SF-36) and, functional status was assessed using the six-minute walk test (6MWT), the Fatigue Severity Scale (FSS), the Med-ical Research Council (MRC) Dyspnea Scale and, the Post-COVID-19 Functional Status Scale (PCFS). Results: Were included 123 patients, 73 (59.35%) were male, with a mean age of 49.17±13.48 years and a body mass index of 31.02±6.56 stratified into three groups, not recov-ered group (NRG=23), ward recovered group (WHG=60), and intensive care unit group (ICUG=40). The main symptoms were muscle weakness (74.17%) and dyspnea (68.33%). In rela-tion to the distance covered in the 6MWT, the GNR group walked 12.83% below the predicted values, GNR 20.21% and the UGCI 28.82%, respectively. The MRC dyspnea scale had a mean value of less than 3 and the FSS scale had a mean value over 4, indicating considerable fatigue. In the PCFS scale, a significant difference was observed (p>0.0005); while in the SF-36, all HRQoL domains were compromised. Conclusion: Post-COVID-19 patients involved in this study showed a significant decline in functional status and an impairment of HRQoL.
- Open Access
- 1 July 2024
- Published by Brazilian Journals in Cuadernos de Educación y Desarrollo
- Vol. 16 (7) , e4895
Principles of pulmonary rehabilitation for patients with chronic obstructive pulmonary disease - a narrative review
A doença pulmonar obstrutiva crônica (DPOC) é uma síndrome heterogênea causada por diversos processos fisiopatológicos que comprometem as vias aéreas superiores e inferiores, com diferentes manifestações clínicas, evolução e respostas ao tratamento. Os pacientes com DPOC apresentam disfunção muscular periférica significativa devido ao sedentarismo e inflamação sistêmica, alterações nutricionais, hipoxemia, estresse oxidativo e corticoterapia. A literatura científica recomenda que a prática de exercícios anaeróbicos isoladamente ou em associação com exercícios aeróbicos interrompe o ciclo vicioso causado pela dispneia, melhorando a capacidade funcional, a independência nas atividades da vida diária e a qualidade de vida relacionada à saúde. O Programa de Reabilitação Pulmonar, definido como uma intervenção multidisciplinar baseada na avaliação e no tratamento personalizado, incluindo treinamento físico, educação e modificação comportamental destinada a melhorar a condição física e psicológica de pessoas com distúrbios respiratórios, tem indicação clínica como intervenção complementar ao tratamento farmacológico. Este estudo teve como objetivo apresentar e discutir os princípios da reabilitação pulmonar para pacientes com DPOC, com foco na avaliação, treinamento e manutenção em longo prazo. Esta revisão narrativa foi realizada por meio de buscas das referências nas bases de dados MEDLINE/PubMed, Cochrane Library e SciELO. Pode-se concluir que para o envolvimento e adesão dos pacientes com DPOC ao PRP, a avaliação inicial, acompanhamento, reavaliação, manutenção após a alta deve ser baseada em um plano de tratamento individualizado para cada paciente, visando melhorar a execução e segurança.
- 1 July 2024
- Published by Brazilian Journals in Cuadernos de Educación y Desarrollo
- Vol. 16 (7) , e4895
Open AccessPrinciples of pulmonary rehabilitation for patients with chronic obstructive pulmonary disease - a narrative review
A doença pulmonar obstrutiva crônica (DPOC) é uma síndrome heterogênea causada por diversos processos fisiopatológicos que comprometem as vias aéreas superiores e inferiores, com diferentes manifestações clínicas, evolução e respostas ao tratamento. Os pacientes com DPOC apresentam disfunção muscular periférica significativa devido ao sedentarismo e inflamação sistêmica, alterações nutricionais, hipoxemia, estresse oxidativo e corticoterapia. A literatura científica recomenda que a prática de exercícios anaeróbicos isoladamente ou em associação com exercícios aeróbicos interrompe o ciclo vicioso causado pela dispneia, melhorando a capacidade funcional, a independência nas atividades da vida diária e a qualidade de vida relacionada à saúde. O Programa de Reabilitação Pulmonar, definido como uma intervenção multidisciplinar baseada na avaliação e no tratamento personalizado, incluindo treinamento físico, educação e modificação comportamental destinada a melhorar a condição física e psicológica de pessoas com distúrbios respiratórios, tem indicação clínica como intervenção complementar ao tratamento farmacológico. Este estudo teve como objetivo apresentar e discutir os princípios da reabilitação pulmonar para pacientes com DPOC, com foco na avaliação, treinamento e manutenção em longo prazo. Esta revisão narrativa foi realizada por meio de buscas das referências nas bases de dados MEDLINE/PubMed, Cochrane Library e SciELO. Pode-se concluir que para o envolvimento e adesão dos pacientes com DPOC ao PRP, a avaliação inicial, acompanhamento, reavaliação, manutenção após a alta deve ser baseada em um plano de tratamento individualizado para cada paciente, visando melhorar a execução e segurança.